5-Minute Pharma Daily(feeds.transistor.fm)
Webinar: From Facility to Delivery: Solving the Complex Science of ADC Linker-Payload SynthesisUniQure crashes as Huntington’s gene therapy shows less slowing of disease at 4 yearsRoche cuts muscle-sparing obesity drug after mid-stage disappointmentSummit snags $2B investment from AstraZeneca, clearing financial overhangNovo adds long-term obesity differentiation in up to $2.6B Hengrui deal3 steps for taking on Novartis in radiopharma: Curium up firstKodiak Sciences’ stock soars 166% after 2 assets match Eylea in Phase 3 trial
BioPharma Dive - Latest News(biopharmadive.com)
PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approvalBeam sues 2 biotechs, alleging theft of base editing trade secretsNovo to pay Hengrui up to $2.6B for a once-weekly obesity pillUniQure tumbles with latest data for Huntington’s gene therapyai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’AstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug pushKodiak skyrockets on positive study data for 2 eye drugs
AbbVie Juvmo FDA Approved: Parkinson's Breakthrough | Pharma and Biotech DailyMerck's FDA Win: Welireg & Lenvima Breakthrough | Pharma and Biotech DailyEli Lilly's $2B Onswik FDA Approval Revolutionizes Diabetes | Pharma and Biotech DailyAstraZeneca's Trixeo EU Approval & Boehringer's $250M Deal | Pharma and Biotech DailyBoehringer Ingelheim's $1B AI Deal & FDA Trials Update | Pharma and Biotech DailyTelix Buys ITM for $2.35B | Pharma and Biotech DailyUltragenyx’s $4M Fayuvi FDA Approval Breakthrough | Pharma and Biotech Daily
NICE backs first systemic therapy for desmoid tumoursAbbVie wins EU approval for paediatric pJIA useInvestor horizons ahead of CPHI 2026Lexeo expands Friedreich ataxia pipeline with Mantle dealAC immune reports week-100 progress in VacSyn trialCarvykti delivers five-year remissions in early myelomaGrünenthal expands pain portfolio across Asia-Pacific
STAT+: At MAHA Summit, a grassroots movement goes corporateSTAT+: Lawmakers urge Trump to rethink new rule that could restrict imported meds from Canada and overseasSTAT+: PhRMA taps Eric Cantor as new CEOSTAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual propertySTAT+: Overton won’t get a vote before midtermsSTAT+: Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care eventSTAT+: AstraZeneca invests $2 billion in Summit Therapeutics